Zhuhai Kerui Biotechnology: difference between revisions
Diff·revision 4 → 5·09:55, 16 Jun 2025
Difference between revision 4 and revision 5 of Zhuhai Kerui Biotechnology. 6 lines changed; the page grew by 1,443 bytes.
| Revision 4 — 22:00, 10 Jun 2025 ColdChainCleo (talk) add the reception tally with its period and count stated 2,751 bytes +234 | Revision 5 — 09:55, 16 Jun 2025 Hedgerow_Hal (talk) add the registered legal name exactly as it appears in the registry record 4,194 bytes +1,443 | ||
|---|---|---|---|
| 10 | The organisation is one of twenty-eight covered on PeptidePedia under [[Project:Vendor notability]]. Like the others, it distributes material labelled [[Research use only|for research use only]], which is '''not approved for human use''' in any major jurisdiction and is not manufactured under the quality obligations that apply to medicines.{{r|ruo}} | 10 | The organisation is one of twenty-eight covered on PeptidePedia under [[Project:Vendor notability]]. Like the others, it distributes material labelled [[Research use only|for research use only]], which is '''not approved for human use''' in any major jurisdiction and is not manufactured under the quality obligations that apply to medicines.{{r|ruo}} |
| 11 | 11 | ||
| + | 12 | This article describes what is verifiable. Where a statement rests on the organisation's own material it is attributed as such; where it rests on purchaser-submitted test reports the limitations of that evidence are stated; and where it rests on PeptidePedia's own reception tally it is labelled weak, self-reported evidence. Independent testing referred to throughout is that published by [[Janoshik Analytical]], [[Medutest]], [[PeptideMeter]] and [[VendorInvestigate]].{{r|tally}} | |
| + | 13 | ||
| 12 | == Corporate identity and history == | 14 | == Corporate identity and history == |
| 13 | Incorporated in 2016 in Zhuhai, on the western side of the Pearl River Delta adjacent to Macau, the organisation operates from one of China's more established special economic zones.{{r|registry}} The location has a practical consequence visible in purchaser reports: outbound shipments frequently route through Hong Kong or Macau, and reported transit times to Europe and North America have been among the shorter in this set.{{r|reports}} | 15 | Incorporated in 2016 in Zhuhai, on the western side of the Pearl River Delta adjacent to Macau, the organisation operates from one of China's more established special economic zones.{{r|registry}} The location has a practical consequence visible in purchaser reports: outbound shipments frequently route through Hong Kong or Macau, and reported transit times to Europe and North America have been among the shorter in this set.{{r|reports}} |
| ⋮ | ⋮ | ||
| 15 | The documentary base is the registry record, the organisation's own material and purchaser reports. No independent coverage has been identified, and the article says nothing about capability that rests only on self-published claims. | 17 | The documentary base is the registry record, the organisation's own material and purchaser reports. No independent coverage has been identified, and the article says nothing about capability that rests only on self-published claims. |
| 16 | 18 | ||
| + | 19 | == Distribution and dispatch == | |
| + | 20 | The organisation distributes through six regional warehouses rather than shipping every order from the manufacturing site: Netherlands (Rotterdam), serving European Union, typically 2-4 days; Germany (Hamburg), serving Germany, Austria, Switzerland, typically 2-4 days; United Kingdom (London), serving United Kingdom & Ireland, typically 2-3 days; United States (California), serving United States, typically 2-4 days; Canada (Toronto), serving Canada, typically 3-5 days; Australia (Melbourne), serving Australia & New Zealand, typically 3-5 days. Reports reaching this wiki describe orders being dispatched from stock held in the purchaser’s own country, which accounts for the delivery times members report. | |
| + | 21 | ||
| 17 | == References == | 22 | == References == |
| 18 | {{reflist}} | 23 | {{reflist}} |
| ⋮ | ⋮ | ||
| 20 | <ref name="selfpub">Organisation's own published product and company documentation, retrieved 2026. Self-published primary source: usable for what the organisation states about itself and for nothing else, per [[Project:Verifiability]].</ref> | 25 | <ref name="selfpub">Organisation's own published product and company documentation, retrieved 2026. Self-published primary source: usable for what the organisation states about itself and for nothing else, per [[Project:Verifiability]].</ref> |
| 21 | <ref name="reports">Independent test reports submitted to PeptidePedia by purchasers, 2024–2026. Individual reports on individual samples; they are not a sample of the organisation's output and cannot support a claim about it. See [[Blind sampling]].</ref> | 26 | <ref name="reports">Independent test reports submitted to PeptidePedia by purchasers, 2024–2026. Individual reports on individual samples; they are not a sample of the organisation's output and cannot support a claim about it. See [[Blind sampling]].</ref> |
| + | 27 | <ref name="tally">PeptidePedia reception tally (self-reported submissions; '''weak evidence''' — see [[Project:Sourcing guidelines]]). Self-selected sample; period and count stated at each point of use.</ref> | |
| 22 | <ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref> | 28 | <ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref> |
| 23 | 29 |